National Institute of Allergy and Infectious Diseases; Notice of Closed Meeting, 2128-2129 [2011-581]
Download as PDF
2128
Federal Register / Vol. 76, No. 8 / Wednesday, January 12, 2011 / Notices
TABLE 1—ESTIMATED ANNUAL REPORTING BURDEN1
Annual
frequency
per
response
Number of
respondents
21 CFR section
Total annual
responses
Hours per
response
Total hours
60.24(a) ................................................................................
60.30 ....................................................................................
60.40 ....................................................................................
1
1
1
1
1
1
1
1
1
100
50
10
100
50
10
Total ..............................................................................
........................
........................
........................
........................
160
1 There
are no capital costs or operating and maintenance costs associated with this collection of information.
Dated: January 5, 2011.
Leslie Kux,
Acting Assistant Commissioner for Policy.
[FR Doc. 2011–459 Filed 1–11–11; 8:45 am]
Dated: January 6, 2011.
Jennifer S. Spaeth,
Director, Office of Federal Advisory
Committee Policy.
BILLING CODE 4160–01–P
[FR Doc. 2011–583 Filed 1–11–11; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
mstockstill on DSKH9S0YB1PROD with NOTICES
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
hereby given of the following meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Heart, Lung,
and Blood Institute Special Emphasis Panel,
Loan Repayment Program Review.
Date: February 1, 2011.
Time: 8 a.m. to 11 a.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 6701
Rockledge Drive, Bethesda, MD 20892.
(Virtual Meeting.)
Contact Person: Tony L Creazzo, PhD,
Scientific Review Officer, Office of Scientific
Review/DERA, National Heart, Lung, and
Blood Institute, 6701 Rockledge Drive, Room
7180, Bethesda, MD 20892–7924. 301–435–
0725. creazzotl@mail.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.233, National Center for
Sleep Disorders Research; 93.837, Heart and
Vascular Diseases Research; 93.838, Lung
Diseases Research; 93.839, Blood Diseases
and Resources Research, National Institutes
of Health, HHS)
20:49 Jan 11, 2011
Jkt 223001
Dated: January 6, 2011.
Jennifer Spaeth,
Director, Office of Federal Advisory
Committee Policy.
[FR Doc. 2011–582 Filed 1–11–11; 8:45 am]
National Institutes of Health
National Heart, Lung, and Blood
Institute; Notice of Closed Meeting
VerDate Mar<15>2010
Training; 93.273, Alcohol Research Programs;
93.891, Alcohol Research Center Grants;
93.701, ARRA Related Biomedical Research
and Research Support Awards, National
Institutes of Health, HHS)
BILLING CODE 4140–01–P
National Institute on Alcohol Abuse
and Alcoholism; Notice of Closed
Meeting
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App), notice is
hereby given of the following meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable materials,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Institute on
Alcohol Abuse and Alcoholism Initial
Review Group. Epidemiology, Prevention
and Behavior Research Review
Subcommittee.
Date: March 29–30, 2011.
Time: 8 a.m. to 5 p.m.
Agenda: To review and evaluate grant
applications.
Place: Hyatt Regency Bethesda, One
Bethesda Metro Center, 7400 Wisconsin
Avenue, Bethesda, MD 20814.
Contact Person: Ranga V. Srinivas, PhD,
Scientific Review Officer, National Institute
on Alcohol Abuse and Alcoholism,
Extramural Project Review Branch, 5635
Fishers Lane, Room 2085, Bethesda, MD
20892. 301–451–2067. srinivar@mail.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.271, Alcohol Research
Career Development Awards for Scientists
and Clinicians; 93.272, Alcohol National
Research Service Awards for Research
PO 00000
Frm 00048
Fmt 4703
Sfmt 4703
National Institutes of Health
National Institute of Allergy and
Infectious Diseases; Notice of Closed
Meeting
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
hereby given of the following meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: Microbiology,
Infectious Diseases and AIDS Initial Review
Group. Microbiology and Infectious Diseases
B Subcommittee.
Date: February 10–11, 2011.
Time: 8 a.m. to 6 p.m.
Agenda: To review and evaluate grant
applications.
Place: Courtyard by Marriott, 5520
Wisconsin Avenue, Chevy Chase, MD 20815.
Contact Person: Gary S. Madonna, PhD,
Scientific Review Officer, Scientific Review
Program, Division of Extramural Activities,
NIAID, National Institutes of Health, 6700B
Rockledge Drive, MSC 7616, Bethesda, MD
20892. 301–496–3528. gm12w@nih.gov.
E:\FR\FM\12JAN1.SGM
12JAN1
Federal Register / Vol. 76, No. 8 / Wednesday, January 12, 2011 / Notices
Dated: January 6, 2011.
Jennifer S. Spaeth,
Director, Office of Federal Advisory
Committee Policy.
[FR Doc. 2011–579 Filed 1–11–11; 8:45 am]
BILLING CODE 4140–01–P
National Institutes of Health
National Institute on Alcohol Abuse
and Alcoholism; Notice of Closed
Meeting
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App), notice is
hereby given of the following meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable materials,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Institute on
Alcohol Abuse and Alcoholism, Special
Emphasis Panel, ‘‘Review of the Prenatal
Alcohol in Sudden Infant Death Syndrome
And Stillbirth (PASS) Network’’ (RFA HD
10–018).
Date: February 28, 2011.
Time: 8 a.m. to 6 p.m.
Agenda: To review and evaluate grant
applications.
Place: Hyatt Regency Bethesda, One
Bethesda Metro Center, 7400 Wisconsin
Avenue, Bethesda, MD 20814.
Contact Person: Richard Rippe, PhD,
Scientific Review Officer, National Institute
on Alcohol Abuse and Alcoholism, National
Institutes of Health, 5635 Fishers Lane, Room
2109, Bethesda, MD 20852. 301–443–8599.
rippera@mail.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.271, Alcohol Research
Career Development Awards for Scientists
and Clinicians; 93.272, Alcohol National
Research Service Awards for Research
Training; 93.273, Alcohol Research Programs;
93.891, Alcohol Research Center Grants;
93.701, ARRA Related Biomedical Research
and Research Support Awards., National
Institutes of Health, HHS)
Jkt 223001
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institute of Neurological
Disorders and Stroke; Notice of
Meeting
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
mstockstill on DSKH9S0YB1PROD with NOTICES
[FR Doc. 2011–580 Filed 1–11–11; 8:45 am]
National Institutes of Health
BILLING CODE 4140–01–P
20:49 Jan 11, 2011
Dated: January 5, 2011.
Jennifer S. Spaeth,
Director, Office of Federal Advisory
Committee Policy.
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
[FR Doc. 2011–581 Filed 1–11–11; 8:45 am]
VerDate Mar<15>2010
Dated: January 5, 2011.
Jennifer Spaeth,
Director, Office of Federal Advisory
Committee Policy.
BILLING CODE 4140–01–P
(Catalogue of Federal Domestic Assistance
Program Nos. 93.855, Allergy, Immunology,
and Transplantation Research; 93.856,
Microbiology and Infectious Diseases
Research, National Institutes of Health, HHS)
2129
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
hereby given of a meeting of the
National Advisory Neurological
Disorders and Stroke Council.
The meeting will be open to the
public, with attendance limited to space
available. Individuals who plan to
attend and need special assistance, such
as sign language interpretation or other
reasonable accommodations, should
notify the Contact Person listed below
in advance of the meeting.
Name of Committee: National Advisory
Neurological Disorders and Stroke Council,
Basic and Preclinical Programs
Subcommittee.
Date: February 3, 2011.
Time: 8 a.m. to 10 a.m.
Agenda: To discuss basic and preclinical
programs policy.
Place: National Institutes of Health,
Building 31, 31 Center Drive, Conference
Room #7, Bethesda, MD 20892.
Contact Person: William D. Matthew, MD,
Director, Office of Translational Research,
NINDS, National Institutes of Health, 6001
Executive Blvd., Room 2137, Bethesda, MD
20892. 301–496–1779. bill.matthew@nih.gov.
In the interest of security, NIH has
instituted stringent procedures for entrance
onto the NIH campus. All visitor vehicles,
including taxicabs, hotel, and airport shuttles
will be inspected before being allowed on
campus. Visitors will be asked to show one
form of identification (for example, a
government-issued photo ID, driver’s license,
or passport) and to state the purpose of their
visit.
Information is also available on the
Institute’s/Center’s home page: https://
www.ninds.nih.gov, where and agenda and
any additional information for the meeting
will be posted when available.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.853, Clinical Research
Related to Neurological Disorders; 93.854,
Biological Basis Research in the
Neurosciences, National Institutes of Health,
HHS)
PO 00000
Frm 00049
Fmt 4703
Sfmt 4703
National Institute of Neurological
Disorders And Stroke; Notice of
Meeting
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
hereby given of a meeting of the
National Advisory Neurological
Disorders and Stroke Council.
The meeting will be open to the
public as indicated below, with
attendance limited to space available.
Individuals who plan to attend and
need special assistance, such as sign
language interpretation or other
reasonable accommodations, should
notify the Contact Person listed below
in advance of the meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Advisory
Neurological Disorders and Stroke Council
Clinical Trials Subcommittee.
Date: February 2–3, 2011.
Closed: February 2, 2011, 6:30 p.m. to 7:45
p.m.
Agenda: To review and evaluate grant
applications.
Place: Hyatt Regency Bethesda, One
Bethesda Metro Center, 7400 Wisconsin
Avenue, Bethesda, MD 20814.
Open: February 3, 2011, 8 a.m. to 10 a.m.
Agenda: To discuss clinical trials policy.
Place: National Institutes of Health,
Building 31, 31 Center Drive, Conference
Room #10, Bethesda, MD 20892.
Contact Person: Petra Kaufmann, MD.,
Director, Office of Clinical Research-NINDS,
National Institutes of Health, Neuroscience
Center-Room 2216, 6001 Executive Blvd.,
Bethesda, MD 20892. 301–496–9135.
Kaufmanp2@ninds.nih.gov.
In the interest of security, NIH has
instituted stringent procedures for entrance
onto the NIH campus. All visitor vehicles,
including taxicabs, hotel, and airport shuttles
will be inspected before being allowed on
E:\FR\FM\12JAN1.SGM
12JAN1
Agencies
[Federal Register Volume 76, Number 8 (Wednesday, January 12, 2011)]
[Notices]
[Pages 2128-2129]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2011-581]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
National Institute of Allergy and Infectious Diseases; Notice of
Closed Meeting
Pursuant to section 10(d) of the Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is hereby given of the following
meeting.
The meeting will be closed to the public in accordance with the
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5
U.S.C., as amended. The grant applications and the discussions could
disclose confidential trade secrets or commercial property such as
patentable material, and personal information concerning individuals
associated with the grant applications, the disclosure of which would
constitute a clearly unwarranted invasion of personal privacy.
Name of Committee: Microbiology, Infectious Diseases and AIDS
Initial Review Group. Microbiology and Infectious Diseases B
Subcommittee.
Date: February 10-11, 2011.
Time: 8 a.m. to 6 p.m.
Agenda: To review and evaluate grant applications.
Place: Courtyard by Marriott, 5520 Wisconsin Avenue, Chevy
Chase, MD 20815.
Contact Person: Gary S. Madonna, PhD, Scientific Review Officer,
Scientific Review Program, Division of Extramural Activities, NIAID,
National Institutes of Health, 6700B Rockledge Drive, MSC 7616,
Bethesda, MD 20892. 301-496-3528. gm12w@nih.gov.
[[Page 2129]]
(Catalogue of Federal Domestic Assistance Program Nos. 93.855,
Allergy, Immunology, and Transplantation Research; 93.856,
Microbiology and Infectious Diseases Research, National Institutes
of Health, HHS)
Dated: January 6, 2011.
Jennifer S. Spaeth,
Director, Office of Federal Advisory Committee Policy.
[FR Doc. 2011-581 Filed 1-11-11; 8:45 am]
BILLING CODE 4140-01-P